3
Views
92
CrossRef citations to date
0
Altmetric
Research Article

Upstream Stimulatory Factor Regulates Expression of the Cell Cycle-Dependent Cyclin B1 Gene Promoter

, , , &
Pages 2782-2790 | Received 21 Oct 1994, Accepted 17 Feb 1995, Published online: 30 Mar 2023

REFERENCES

  • Adami, G., and L. E. Babiss. 1992. Evidence that USF can interact with only a single general transcription complex at one time. Mol. Cell. Biol. 12:1630–1638.
  • Azizkhan, J. C., D. E. Jensen, A. J. Pierce, and M. Wade. 1993. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryotic Gene Expression 3:229–254.
  • Beg, A. A., T. S. Finco, P. V. Nantermet, and A. S. Baldwin, Jr. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:3301–3310.
  • Bendall, A. J., and P. L. Molloy. 1994. Base preferences for DNA binding by the bHLH-Zip protein USF: effects of MgCl2 on specificity and comparison with binding of Myc family members. Nucleic Acids Res. 22:2801–2810.
  • Blackwell, T. K., J. Huang, A. Ma, L. Kretzner, F. W. Alt, R. N. Eisenman, and H. Weintraub. 1993. Binding of Myc proteins to canonical and nonca-nonical DNA sequences. Mol. Cell. Biol. 13:5216–5224.
  • Buchou, T., O. Kranenburg, H. van Dam, D. Roelen, A. Zantema, F. L. Hall, and A. van der Eb. 1993. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines. Oncogene 8:1765–1773.
  • Buckley, M. F., K. J. E. Sweeney, J. A. Hamilton, R. L. Sini, D. L. Manning, R. I. Nicholson, A. DeFazio, C. K. W. Watts, E. A. Musgrove, and R. L. Sutherland. 1993. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127–2133.
  • Chandra, G., P. Patel, T. A. Kost, and J. G. Gray. 1992. Large scale purifi-cation of plasmid DNA by fast protein liquid chromatography using a high load Q sepharose column. Anal. Biochem. 203:169–172.
  • Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299.
  • Chodosh, L. A., R. W. Carthew, J. G. Morgan, G. R. Crabtree, and P. A. Sharp. 1987. The adenovirus major late transcription factor activates the rat-γ-fibrinogen promoter. Science 238:684–688.
  • Cogswell, J. P., M. M. Godlevski, G. B. Wisely, W. C. Clay, L. M. Leesnitzer, J. P. Ways, and J. G. Gray. 1994. NF-κB regulates IL-1β transcription through a consensus NF-κB binding site and a nonconsensus CRE-like site. J. Immunol. 153:712.
  • Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J. 11:1797–1804.
  • Doree, M. 1990. Control of M-phase by maturation-promoting factor. Curr. Opin. Cell Biol. 2:269–273.
  • Du, H., A. L. Roy, and R. G. Roeder. 1993. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 12:501–511.
  • Faisst, S., and S. Meyer. 1992. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20:3–26.
  • Gallant, P., and E. A. Nigg. 1994. Identification of a novel vertebrate cyclin: cyclin B3 shares properties with both A- and B-type cyclins. EMBO J. 13:595–605.
  • Gautier, J., J. Minshull, M. Lohka, M. Glotzer, T. Hunt, and J. L. Maller. 1990. Cyclin is a component of maturation promoting factor from Xenopus. Cell 60:487–494.
  • Gautier, J., C. Nrobury, M. Lohka, P. Nurse, and J. L. Maller. 1988. Purified maturation promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene cdc21. Cell 54:433–439.
  • Glotzer, M., A. W. Murray, and M. W. Kirschner. 1991. Cyclin is degraded by the ubiquitin pathway. Nature (London) 349:132–138.
  • Gong, J., B. Ardelt, F. Traganos, and Z. Darzynkiewicz. 1994. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor lines. Cancer Res. 54:4285–4288.
  • Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
  • Gregor, P. D., M. Sawadogo, and R. G. Roeder. 1990. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev. 4:1730–1740.
  • Heintz, N., H. L. Sive, and R. G. Roeder. 1989. Regulation of human histone gene expression: kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle. Mol. Cell. Biol. 3:539–550.
  • Henglein, B., X. Chenivesse, J. Wang, D. Eick, and C. Brechot. 1994. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc. Natl. Acad. Sci. USA 91:5490–5494.
  • Herbst, R. S., E. M. Boczko, J. E. Darnell, and L. E. Babiss. 1990. The mouse albumin enhancer contains a negative regulatory element that interacts with a novel DNA-binding protein. Mol. Cell. Biol. 10:3896–3905.
  • Hinds, P. W., S. F. Dowdy, E. N. Eaton, A. Arnold, and R. A. Weinberg. 1994. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91:709–713.
  • Hoang, A. T., K. J. Cohen, J. F. Barrett, D. A. Bergstrom, and C. V. Dang. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA 91:6875–6879.
  • Jansen-Durr, P., A. Meichle, P. Steiner, M. Pagano, K. Finke, J. Botz, J. Wessbecher, G. Draetta, and M. Eilers. 1993. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA 90:3685–3689.
  • Jiang, W., S. M. Kahn, N. Tomita, Y.-J. Zhang, S.-H. Lu, and I. B. Wienstein. 1992. Amplification and expression of the human cyclin D gene in esopho-geal cancer. Cancer Res. 52:2980–2983.
  • Jiang, W., S. M. Kahn, P. Zhou, Y.-J. Zhang, A. M. Cacace, A. S. Infante, S. Doi, R. M. Santella, and I. B. Weinstein. 1993. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression, and gene expression. Oncogene 8:3447–3457.
  • Keyomarsi, K., N. O'Leary, G. Molnar, E. Lees, H. J. Fingert, and A. B. Pardee. 1994. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res. 54:380–385.
  • Lemaigre, F. P., S. J. Courtois, D. A. Lafontaine, and G. G. Rousseau. 1989. Evidence that the upstream stimulatory factor and the Sp1 transcription factor bind in vitro to the promoter of the human-growth-hormone gene. Eur. J. Biochem. 181:555–561.
  • Meijer, L., D. Arion, R. Golsteyn, J. Pines, L. Brizuela, T. Hunt, and D. Beach. 1989. Cyclin is a component of the sea urchin egg M-phase specific histone H1 kinase. EMBO J. 8:2275–2282.
  • Motokura, T., and A. Arnold. 1993. PRAD1/cyclin D1 proto-oncogene: genomic organization, 59 DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer 7:89–95.
  • Mount, S. M. 1982. A catalogue of splice junction sequences. Nucleic Acids Res. 10:459.
  • Muller, H., J. Lukas, A. Schneider, P. Warthoe, J. Bartek, M. Eilers, and M. Strauss. 1994. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. USA 91:2945–2949.
  • Nigg, E. A. 1993. Cellular substrates of p34cdc2 and its companion cyclin-dependent kinases. Trends Cell Biol. 3:296–301.
  • Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961–971.
  • Peffer, N. J., J. C. Hanvey, J. E. Bisi, S. A. Thomson, C. F. Hassman, S. A. Noble, and L. E. Babiss. 1993. Strand-invasion of duplex DNA by peptide nucleic acid oligomers. Proc. Natl. Acad. Sci. USA 90:10648–10652.
  • Philipp, A., A. Schneider, I. Vasrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers. 1994. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14:4032–4043.
  • Pines, J., and T. Hunter. 1989. Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58:833–846.
  • Pines, J., and T. Hunter. 1990. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature (London) 346:760–763.
  • Pines, J., and T. Hunter. 1990. p34cdc2: the S and M kinase? New Biol. 2:389–401.
  • Potter, J. J., D. Cheneval, C. V. Dang, L. M. S. Resar, E. Mezey, and V. W. Yang. 1991. The upstream stimulatory factor binds to and activates the promoter of the rat class I alcohol dehydrogenase gene. J. Biol. Chem. 266:15457–15463.
  • Quelle, D. E., R. A. Ashmun, S. A. Shurleff, J.-Y. Kato, D. Barsagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerate G1 phase in rodent fibroblasts. Genes Dev. 7:1559–1571.
  • Rao, S. S., C. Chu, and D. S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259–5267.
  • Reach, M., L. E. Babiss, and C. S. H. Young. 1990. The upstream factor-binding site is not essential for activation of transcription from the adeno-virus major late promoter. J. Virol. 64:5851–5860.
  • Reisman, D., and V. Rotter. 1993. The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene. Nucleic Acids Res. 21:345–350.
  • Roy, A. L., M. Meisterernst, P. Pogonec, and R. G. Roeder. 1991. Cooperative interaction of an initiator-binding transcription factor and the helix-loop-helix activator USF. Nature (London) 354:245–248.
  • Sanger, F. S., I. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
  • Sato, M., S. Ishizawa, T. Yoshida, and S. Shibahara. 1990. Interaction of upstream stimulatory factor with the human heme oxygenase promoter. Eur. J. Biochem. 188:231–237.
  • Sawadogo, M., and R. G. Roeder. 1985. Factors involved in specific transcription of mammalian RNA polymerase II: analysis by a rapid and quantitative in vitro assay. Proc. Natl. Acad. Sci. USA 82:4394–4398.
  • Schauer, I. E., S. Siriwardana, T. A. Langan, and R. A. Sclafani. 1994. Cyclin D1 overexpression versus retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc. Natl. Acad. Sci. USA 91:7827–7831.
  • Scotto, K. W., H. Kaulen, and R. G. Roeder. 1989. Positive and negative regulation of the gene for transcription factor IIIA in Xenopus laevis oocytes. Genes Dev. 3:651–662.
  • Sirito, M., S. Walker, Q. Lin, M. T. Kozlowski, W. H. Klein, and M. Sawadogo. 1992. Members of the USF family of helix-loop-helix proteins bind DNA as homo- as well as heterodimers. Gene Expression 2:231–240.
  • Solomon, M. J., M. Glotzer, T. H. Lee, M. Philipe, and M. W. Kirschner. 1990. Cyclin activation of p34cdc2. Cell 63:1013–1034.
  • Spitovsky, D., P. Steiner, J. Lukas, E. Lees, M. Pagano, A. Schulze, S. Joswig, D. Picard, M. Tommasino, M. Eilers, and P. Jansen-Durr. 1994. Modulation of cyclin gene expression by adenovirus E1A in a cell line with E1A-dependent conditional proliferation. J. Virol. 68:2206–2214.
  • Van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050–2054.
  • Van Dyke, M., M. Sirito, and M. Sawadogo. 1992. Single step purification of bacterially expressed polypeptides containing an oligo-histidine domain. 1992. Gene 111:99–104.
  • Wang, T. C., R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (London) 369:669–671.
  • White, R. A., N. H. A. Terry, M. L. Meistrich, and D. P. Calkins. 1990. Improved method for computing potential doubling time from flow cytomet-ric data. Cytometry 11:314–317.
  • Yamamoto, M., M. Yoshida, K. Ono, T. Fujita, N. Ohtani-Fujita, T. Sakai, and T. Nikaido. 1994. Effect of tumor suppressors on cell cycle-regulatory genes: RB suppresses p34cdc2 expression and normal p53 suppresses cyclin A expression. Exp. Cell Res. 210:94–101.
  • Zieve, G. W., D. Turnbull, J. M. Mullins, and J. R. McIntosh. 1980. Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Exp. Cell Res. 126:397–405.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.